The Gender Gap in Diabetes Risk: Why Men and Women Are Not Created Equal

Diabetes mellitus, particularly type 2 diabetes, continues to be one of the most pressing global health challenges, affecting over 500 million adults worldwide. Yet beneath the broad statistics lies a critical nuance: a person's sex significantly influences their risk of developing the disease. Research consistently demonstrates that men and women exhibit different diabetes risk scores, meaning the factors that raise a man’s risk may not carry the same weight for a woman, and vice versa. Understanding these distinctions is not merely an academic exercise—it can reshape how clinicians screen, counsel, and treat patients. This article delves into the biological, hormonal, lifestyle, and clinical reasons behind these differing risk profiles and explores what healthcare providers and individuals can do to leverage this knowledge for better outcomes.

What Exactly Are Diabetes Risk Scores?

Before exploring the gender differences, it is important to understand how diabetes risk is quantified. A diabetes risk score is a set of weighted factors—such as age, body mass index (BMI), family history, physical activity, diet, and blood glucose levels—that estimate an individual’s probability of developing type 2 diabetes within a given time frame. Tools like the Finnish Diabetes Risk Score (FINDRISC) and the American Diabetes Association’s risk test assign points based on these variables. However, many of these models were developed using population data that may not fully account for sex-based differences in physiology and behavior. Recent studies have called for sex-specific risk algorithms because the same score can mean very different things for a man versus a woman. For example, a woman with a certain waist circumference may have a higher risk than a man with the same measurement due to differences in fat distribution and its metabolic consequences.

Biological and Hormonal Drivers of Divergent Risk

Fat Distribution and Body Composition

One of the most well-documented differences between men and women that affects diabetes risk is body fat distribution. Men tend to store fat viscerally—around the internal organs in the abdominal cavity—while women preferentially store fat subcutaneously in the hips, thighs, and buttocks. Visceral fat is metabolically active and highly associated with insulin resistance, inflammation, and dyslipidemia. This means that even at the same total body fat percentage or BMI, a man may have a higher diabetes risk score due to the location of his fat. Conversely, women typically have a higher overall body fat percentage than men, but much of it is subcutaneous, which is less metabolically harmful. However, after menopause, women’s fat distribution shifts toward a more android (male-like) pattern, increasing their insulin resistance and narrowing the risk gap.

Sex Hormones: Estrogen, Testosterone, and Insulin Sensitivity

Sex hormones play a pivotal role in glucose metabolism. Estrogen, particularly the active form estradiol, enhances insulin sensitivity and helps protect against type 2 diabetes. This is why premenopausal women generally have a lower incidence of diabetes than age-matched men. However, during and after menopause, estrogen levels drop sharply, leading to reduced insulin sensitivity and increased risk. Hormone replacement therapy can partially mitigate this but comes with its own risks. Testosterone, on the other hand, has a more complex relationship with diabetes. In men, low testosterone levels are associated with obesity, insulin resistance, and metabolic syndrome, increasing diabetes risk. Conversely, in women, elevated testosterone (as seen in polycystic ovary syndrome, PCOS) is a strong risk factor for type 2 diabetes. These hormonal interactions mean that diabetes risk scores must account for both the sex of the individual and their hormonal status.

Differences in Glucose Homeostasis and Insulin Secretion

Men and women also differ in their baseline glucose metabolism. Studies have shown that women generally have higher insulin sensitivity at the whole-body level, but lower insulin secretion capacity compared to men. This means women may be more vulnerable to developing diabetes when beta-cell function declines. Men, in contrast, tend to have higher insulin resistance but a greater compensatory insulin secretion, at least initially. These differences affect how diabetes manifests: men are more likely to be diagnosed later, with more severe hyperglycemia, while women often present with milder elevations but a faster progression once insulin secretion begins to fail. Risk scores that do not incorporate sex-specific beta-cell function may miss early warning signs in women.

Lifestyle and Behavioral Factors: How Gender Roles Shape Risk

Dietary Patterns and Nutritional Choices

Lifestyle factors further differentiate diabetes risk scores between men and women. Observational data indicate that women tend to consume more vegetables, fruits, and fiber, and have lower intake of red and processed meats compared to men—patterns generally associated with lower diabetes risk. However, women also have a higher prevalence of disordered eating patterns, emotional eating, and dieting-related fluctuations, which can negatively affect metabolic health. Men, on the other hand, are more likely to consume sugary drinks, large portion sizes, and high-fat foods, all of which elevate risk. A risk score that weighs diet equally for both sexes may underestimate the impact for one group if specific behaviors are more prevalent.

Physical Activity and Sedentary Time

Physical activity levels also show a gender divide. Men generally accumulate more moderate-to-vigorous physical activity, especially through occupational and recreational sports. Women often engage in more light-intensity activity and domestic tasks, but overall total activity can be lower. Moreover, sedentary time—such as prolonged sitting—disproportionately affects women’s metabolic health in some studies, possibly due to differences in muscle mass and energy expenditure. Tailoring physical activity recommendations to these patterns can improve the accuracy of risk assessment. For instance, a woman who reports 150 minutes of walking per week may have a different metabolic benefit than a man performing the same amount of vigorous exercise.

Smoking, Alcohol, and Stress

Smoking is a well-known diabetes risk factor, and while smoking rates have declined overall, men still smoke more than women in many populations. However, women who smoke may experience a greater relative increase in insulin resistance compared to men, possibly due to hormonal interactions. Alcohol consumption also shows sex-specific effects: moderate alcohol intake appears to have a protective effect in women but not consistently in men, and heavy drinking increases risk in both groups. Psychological stress, which is more commonly reported by women, raises cortisol levels and can promote abdominal fat accumulation and insulin resistance—another important variable that many risk scores overlook. Including behavioral and psychosocial factors in risk calculations is essential for capturing gender-specific vulnerabilities.

Clinical Implications: Diagnosis, Screening, and Risk Stratification

Do Men and Women Get Diagnosed Differently?

There is evidence that men and women often have different trajectories toward a diabetes diagnosis. Men are more likely to be diagnosed via routine screening or incidental findings, while women are often diagnosed after presenting with symptoms such as infections or complications. This delay in diagnosis for women can lead to higher initial HbA1c levels and more advanced disease at detection. Risk scores that ignore sex-specific presentation patterns may not flag women early enough. Additionally, the standard diagnostic cutoffs for fasting glucose, HbA1c, and oral glucose tolerance test (OGTT) are the same for both sexes, but some researchers argue that sex-specific thresholds could improve early detection in women, who may have slightly lower HbA1c values for the same glucose profile.

The Role of Hormonal Assessments

For women, conditions like PCOS, gestational diabetes (GDM), and early menopause significantly elevate diabetes risk and should be incorporated into risk scoring. A risk score that omits a history of GDM misses one of the strongest predictors for future type 2 diabetes. Similarly, for men, a history of low testosterone or erectile dysfunction can be an early marker of insulin resistance. Including these factors in clinical assessment can improve the predictive power of risk scores and allow for targeted interventions. Providers should consider using sex-specific risk calculators that account for these variables rather than a one-size-fits-all tool.

Tailoring Preventive Strategies

Understanding that men and women have different risk profiles enables more personalized prevention. For example, a woman with a high waist circumference but no family history may need a different prevention plan than a man with the same measurement. Lifestyle interventions may be more effective when adapted to gender: women may respond better to group-based dietary programs, while men may benefit from structured exercise regimens with clear goals. Pharmacologic prevention with metformin has shown similar efficacy in both sexes, but adherence and side effects can differ. Healthcare systems should move toward incorporating sex and gender into risk stratification algorithms, much like they already do for cardiovascular disease.

Future Directions: Improving Risk Scores Through Sex-Specific Research

The current generation of diabetes risk scores, while useful, is largely androcentric or gender-neutral in design. There is a pressing need for large-scale studies that prospectively collect sex-disaggregated data and develop separate risk models for men and women. Emerging research suggests that genetic predisposition to type 2 diabetes differs between sexes, with certain loci showing stronger effects in one sex. Moreover, biomarkers such as sex hormone-binding globulin (SHBG), adiponectin, and inflammatory markers may have sex-specific cutoffs. Incorporating these into risk scores could dramatically increase their accuracy. International organizations, including the World Health Organization and the Diabetes UK risk assessment tools, are beginning to acknowledge these differences, but widespread clinical adoption remains slow.

Practical Takeaways for Clinicians and Patients

For clinicians, the first step is to stop using a single risk score for all patients. Instead, select a tool that either adjusts for sex or use separate algorithms. For example, the FINDRISC includes a sex component, but it does not fully capture hormonal history. A thorough history should include menstrual and reproductive history in women and testosterone-related symptoms in men. For patients, awareness of how sex influences risk can motivate more targeted prevention. A woman with a history of gestational diabetes should be aware that her risk is significantly elevated, even if her current BMI is normal. A man with central obesity should know that his visceral fat is driving insulin resistance more than his overall weight suggests.

  • Implement sex-specific risk assessment – Use tools that account for hormonal history, fat distribution, and gender-specific lifestyle patterns.
  • Customize lifestyle counseling – For women, emphasize stress management, pelvic health, and diet quality; for men, focus on reducing visceral fat and increasing muscle mass.
  • Screen for conditions that alter risk – PCOS, GDM, and early menopause in women; low testosterone and erectile dysfunction in men.
  • Monitor hormonal transitions – Perimenopause, menopause, and andropause are critical windows for reassessing diabetes risk.
  • Encourage research participation – Support studies that analyze sex-specific outcomes to refine future risk scores.

Conclusion

The differences in diabetes risk scores between men and women are real, clinically meaningful, and rooted in a complex interplay of biology, hormones, and behavior. Ignoring these differences leads to missed opportunities for early detection and effective prevention. By adopting a sex-aware approach to diabetes risk assessment, clinicians can move beyond broad population averages toward truly personalized care. As the global diabetes epidemic continues to grow, such nuance is not a luxury—it is a necessity. The goal is not to treat all patients the same, but to give every patient the best possible chance of avoiding diabetes, based on who they are as individuals. Continued research, updated clinical guidelines, and patient education are the pillars that will support this gender-responsive transformation in diabetes care.

For further reading on sex differences in diabetes, see the CDC National Diabetes Statistics Report and the comprehensive review on sex and gender differences in type 2 diabetes published in Diabetologia.